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Madam, I read with interest the article published in the
June 2012 issue of JPMA by ShamimMS et al.1 I have a few
important concerns regarding this article.
Firstly, the authors mention the design of their study as
prospective case control. As an epidemiologist, I disagree
with labeling this study in this category. It appears that all
patients with microdiscectomy were included in the
study. A prospective case-control study is where
participants are selected on the basis of presence or
absence of outcome with their exposure information
prospectively collected. It is an observational study
design where there is no treatment intervention. In this
study, it seems that there was an intervention by the
investigators with the treatment being either midazolam
or saline and the outcome early ambulation and post-
operative pain control. It would best be labeled as a non-
randomized intervention study among patients
undergoing microdiscectomy.
The second point I would like to raise is that the data
presented seem a bit incomplete, particularly in terms of
statistical indicators. It seems the 95% confidence
intervals of the ORs have not been presented, rather the
columns simply say '95'. This is quite important given the
small sample size of the study and to determine how
precise the confidence intervals are that will, in turn,
indicate the power or efficiency of the study.
Thirdly, although the authors indicate that the groups
were comparable with respect to some of the
characteristics mentioned like gender, age, duration of
symptoms, operative time and hospital stay. However, it is
important to understand that the p-value tests are
severely underpowered in this study because of small
sample size and there may actually be differences in these
characteristics between the two groups. The patients may
differ according to other characteristics as well such as
severity of index disease and presence of co-morbidities.
These differences may introduce confounding given the
fact that the study was not a randomized trial. This would
necessitate control for confounding in the analysis
because unadjusted results may be biased and not valid
with limited clinical implications. Given the small number
of outcome events and exposure, it might have been
reasonable to use a propensity score approach to control
at least for the few four or five most important
confounders. Given the prospective nature of the study,
confounder information could have been easily collected.
In summary, the authors fail to mention any of these
epidemiologic limitations of their study in discussion. It
would have also been more reasonable to have the
patients randomized at the start of the study to achieve
baseline exchangeability between the two groups in the
characteristics. Otherwise, control of confounding
becomes necessary.
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